THERAPEUTIC DRUG MONITORING OF BIOLOGICS IN INFLAMMATORY BOWEL DISEASE: NORDIC SURVEY ON IMPLEMENTATION AND BARRIERS IN CLINICAL PRACTICE

被引：0
|
作者：
Bjorlykke, Kristin H.
Jahnsen, Jorgen
Brynskov, Jorn
Molander, Pauliina
Eberhardson, Michael
Davidsdottir, Loa G.
Sipponen, Taina
Hjortswang, Henrik
Langholz, Ebbe
Jorgensen, Kristin K.
Steenholdt, Casper
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1109
引用
收藏
页码：S506 / S506
页数：1
相关论文
共 50 条
  • [31] A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Grossberg, Laurie B.
    Papamichael, Konstantinos
    Feuerstein, Joseph D.
    Siegel, Corey A.
    Ullman, Thomas A.
    Cheifetz, Adam S.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (01) : 191 - 197
  • [32] Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology
    Menz, Bradley D.
    Stocker, Sophie L.
    Verougstraete, Nick
    Kocic, Danijela
    Galettis, Peter
    Stove, Christophe P.
    Reuter, Stephanie E.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (02) : 227 - 236
  • [33] Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
    Wu, Jia-Feng
    GUT AND LIVER, 2021, : 515 - 524
  • [34] Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
    Albader, Farah
    Golovics, Petra Anna
    Gonczi, Lorant
    Bessissow, Talat
    Afif, Waqqas
    Lakatos, Peter Laszlo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (37) : 6231 - 6247
  • [35] Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
    Farah Albader
    Petra Anna Golovics
    Lorant Gonczi
    Talat Bessissow
    Waqqas Afif
    Peter Laszlo Lakatos
    World Journal of Gastroenterology, 2021, 27 (37) : 6231 - 6247
  • [36] Cost-effectiveness of utilising proactive Infliximab therapeutic drug monitoring for inflammatory bowel disease in routine clinical practice
    Steen, J.
    McCormack, M.
    McShane, C.
    Healy, M.
    Crowley, V.
    Kennedy, U.
    Hayes, O.
    Dunne, C.
    Hartery, K.
    McKiernan, S.
    MacCarthy, F.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S307 - S308
  • [37] Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline
    Kawano-Dourado, Leticia
    Kristianslund, Eirik Klami
    Zeraatkar, Dena
    Jani, Meghna
    Makharia, Govind
    Hazlewood, Glen
    Smith, Catherine
    Jess, Tine
    Stabell, Camilla
    Schatten, Arne
    Owen, Andrew
    Gehin, Johanna
    Katsidzira, Leolin
    Weinberg, David
    Bauer-Ventura, Iazsmin
    Tugwell, Peter
    Moayyedi, Paul
    Cecchi, Ana Veronica Wolff
    Shimabuco, Andrea
    Seterelv, Siri
    Gyuatt, Gordon
    Agoritsas, Thomas
    Vandvik, Olav
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 387
  • [38] Therapeutic Drug Monitoring of Adalimumab in Patients With Inflammatory Bowel Disease
    El-Matary, Wael
    CROHNS & COLITIS 360, 2019, 1 (03)
  • [39] Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients on Vedolizumab
    Ansari, Mohammed
    Glassner, Kerri
    Irani, Malcolm
    Perry, Caroline
    Abraham, Bincy P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S435 - S436
  • [40] Therapeutic drug monitoring in inflammatory bowel disease patients on vedolizumab
    Ansari, Mohammed
    Glassner, Kerri
    Irani, Malcolm
    Saleh, Adam
    Wang, Lin
    Ezeana, Chika
    Wong, Stephen
    Perry, Caroline
    Abraham, Bincy
    JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (02) : 91 - 99
12345